Effective price per mg uses an active dated override first, then the row-level historical discount, then the vendor default from the same Git revision. Aggregate chart points include exact-comparability offers only. Missing observations remain gaps; the series does not interpolate across unavailable offers or absent snapshots.

Price watch · beta

Let the market come to you.

Watch the best market price or one vendor. Get one email when Thymalin crosses your target, drops, or sets a new tracked low—without daily noise.

Public product evidence28 certificate records mentioning this compound or product name10 provider-linked · 20 exact product matches

Status

Research Market

This name primarily lives in the research market and should not be read like an approved pharmaceutical product.

Research area

Immune / inflammation research

This profile is grouped by its dominant research area, not by vendor shelf placement.

Aliases

No major aliases are tracked for this profile yet.

Signal depth

Low

No FDA label signal · 0 trials · 234 PubMed results

Preclinical

Research evidence

Current evidence for Thymalin is limited to laboratory or animal studies — there are no name-matched human trials with reported results. Any claims about effects in people are not yet backed by clinical data.

Thymalin has no clinical trials that name it and 234 PubMed-indexed publications and is not FDA-approved. Current evidence is preclinical or mechanistic.

Human data

Lab / animal only

Trial quality

No human trials

Outcomes

No human trials

Replication

Multiple papers

Literature

Established

Bulletin of Experimental Biology and Medicine · 10 citationsEffect of Thymalin on the Tumor and Thymus under Conditions of Activation Therapy In Vivo Vrach · 7 citationsImpact of thymalin on the values of cells, humoral immunity and the life quality in elderly patients with COVID-19 Bulletin of Experimental Biology and Medicine · 7 citationsThymalin: Activation of Differentiation of Human Hematopoietic Stem Cells Journal ArticleExpression features of T-lymphocytes, B-lymphocytes and macrophages in the post-traumatic regenerate of the mandible rats under conditions of filling a bone defect with hydroxyapatite-containing osteotropic material and thymalin injecting the surrounding soft tissues.Journal ArticleReparative osteogenesis in mandible in cases of filling a bone defect with hydroxyapatite-containing osteotropic material and injecting the surrounding soft tissues with thymalin: experimental and morphological study.Journal ArticleThe Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19.

Evidence history

Re-checked nightly against the registries — tracked since 2026-07-09. No band changes yet.

Grades evidence strength, not efficacy or safety. Research-use context; not medical advice. Graded 2026-09-08 from PubMed, ClinicalTrials.gov, ISRCTN, openFDA, Health Canada, and OpenAlex — computed deterministically and refreshed nightly, with a retraction check. How we grade →

What thymalin is

Thymalin is a thymus-derived peptide complex associated with immune-regulation and aging discussions. It often appears in the same broader conversation as thymosin alpha 1, though the compounds are not the same thing.

Why it matters

It strengthens the immune category with another recognizable name and helps the library capture the overlap between immune, longevity, and Eastern European peptide interest.

Regulatory context

Thymalin is not an FDA-approved general-use peptide medicine in the United States and is best handled here as a research-market entry.

Practical reading note

Because immune and aging claims can balloon quickly, it is worth keeping this compound in a clearly non-promotional research frame.